Transdermal estradiol therapy improves bone mineral density (BMD) of men with prostate cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1471, 2005-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anastrozole use does not appear to change bone mineral density (BMD) or bone turnover markers in postmenopausal Japanese women with breast cancer

Reactions Weekly, Vol. 1, Iss. 1122, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Calcium supplementation has minimal effect on bone mineral density (BMD) in healthy children and adolescents

Inpharma, Vol. 1, Iss. 1556, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 17, Iss. 4, 2017-11 ,pp. : 276-284

Bentham Science Publishers

Access to resources Recommend Favorite

Transdermal oxybutynin improves QOL in men with OAB

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 548, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Bisphosphonates to Prevent Osteoporosis in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

By Smith M.R.

Drugs & Aging, Vol. 20, Iss. 3, 2003-01 ,pp. : 175-183

Adis International

Access to resources Recommend Favorite